Enterprise AI platform Vi has unveiled a new suite of vertically specialized AI agents designed specifically for healthcare, life sciences, and wellness organizations—and just closed a $145 million funding round at a $1.64 billion valuation.

The move signals growing investor confidence in AI solutions tailored to regulated industries where precision and compliance matter most. Vi's specialized agents aim to tackle domain-specific challenges in healthcare and wellness, where generic AI tools often fall short. Read the full story →

Today's takeaway: Purpose-built AI for specialized sectors is becoming the next frontier—and investors are backing it heavily.